Literature DB >> 15859969

Diagnosis and treatment of enterovesical fistulae.

D Kavanagh1, P Neary, J D Dodd, K M Sheahan, D O'Donoghue, J M P Hyland.   

Abstract

OBJECTIVE: Enterovesical fistulae are a recognized complication of a variety of inflammatory and neoplastic conditions. Despite advances in imaging and treatment the diagnosis may be delayed and the management remains diverse. We describe our experience with their diagnosis and management. PATIENTS AND METHODS: This retrospective study encompassed all patients referred over a 10-year period with clinical suspicion of or confirmed enterovesical fistula. Demographics, clinical presentation, aetiology and clinical outcome were evaluated. Mean follow-up was 18 months (range 6-50 months).
RESULTS: Thirty patients were studied. The mean age was 63.5 years (range 23-92 years). Fifteen (50%) patients presented with classical urinary symptoms (pneumaturia, faecaluria and recurrent urinary tract infections). The commonest investigations (n, % positive) included CT (15, 80), cystoscopy (16, 87.5), endoscopy (11, 54.5) and barium enema (8, 50). There were 20 inflammatory and 10 neoplastic aetiologies. Five patients were treated conservatively and 25 patients underwent surgery. Surgery resulted in symptomatic cure in the majority of cases (22/25).
CONCLUSION: Classical urinary symptoms were only evident in 50% of patients with confirmed fistulae. We advocate CT scanning as the optimum imaging modality before surgical intervention. Surgical treatment in a specialized unit remains the most effective treatment of enterovesical fistulae.

Entities:  

Mesh:

Year:  2005        PMID: 15859969     DOI: 10.1111/j.1463-1318.2005.00786.x

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  18 in total

Review 1.  Enterovesical fistulas: diagnosis and management.

Authors:  G Scozzari; A Arezzo; M Morino
Journal:  Tech Coloproctol       Date:  2010-07-09       Impact factor: 3.781

2.  Perioperative Management of Patients with Colovesical Fistula.

Authors:  Scott C Dolejs; Alyssa J Penning; Michael J Guzman; Alyssa D Fajardo; Bryan K Holcomb; Bruce W Robb; Joshua A Waters
Journal:  J Gastrointest Surg       Date:  2018-11-08       Impact factor: 3.452

3.  Imaging features of colovesical fistulae on MRI.

Authors:  Y Z Tang; T C Booth; D Swallow; K Shahabuddin; M Thomas; D Hanbury; S Chang; C King
Journal:  Br J Radiol       Date:  2012-06-06       Impact factor: 3.039

4.  Colovaginal and colovesical fistulae: the diagnostic paradigm.

Authors:  D J Holroyd; S Banerjee; M Beavan; R Prentice; V Vijay; S J Warren
Journal:  Tech Coloproctol       Date:  2012-02-14       Impact factor: 3.781

Review 5.  Complicated Diverticular Disease.

Authors:  Kathleen M Coakley; Bradley R Davis; Kevin R Kasten
Journal:  Clin Colon Rectal Surg       Date:  2020-10-21

6.  Laparoscopic bladder-preserving surgery for enterovesical fistula complicated with benign gastrointestinal disease.

Authors:  Tsunekazu Mizushima; Masataka Ikeda; Mitsugu Sekimoto; Hirofumi Yamamoto; Yuichiro Doki; Masaki Mori
Journal:  Case Rep Gastroenterol       Date:  2012-05-23

7.  Vesicocolonic fistula: a sequela of missed blunt abdominal injury.

Authors:  Abdulwahab Akanbi Ajape; Abdullateef Babata; Mustapha Mohammed Kura; Musa Nuhu
Journal:  Case Rep Urol       Date:  2013-01-29

8.  Evaluation of Enteroneovesical Fistula by 64-Detector CT Enterography: A Case Report.

Authors:  Oktay Algin; Melike Rusen Metin; Mustafa Karaoglanoglu
Journal:  Iran J Radiol       Date:  2015-04-21       Impact factor: 0.212

9.  A Rectourethral Fistula due to Transrectal High-Intensity Focused Ultrasound Treatment: Diagnosis and Management.

Authors:  Valeria Fiaschetti; Guglielmo Manenti; Isabelle Di Poce; Maria Fornari; Aurora Ricci; Enrico Finazzi Agrò; Giovanni Simonetti
Journal:  Case Rep Radiol       Date:  2012-12-09

Review 10.  Enterovesical fistulae: aetiology, imaging, and management.

Authors:  Tomasz Golabek; Anna Szymanska; Tomasz Szopinski; Jakub Bukowczan; Mariusz Furmanek; Jan Powroznik; Piotr Chlosta
Journal:  Gastroenterol Res Pract       Date:  2013-11-21       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.